Compounds > quinazolines
Page last updated: 2024-08-21

quinazolines and Capsule Opacification

quinazolines has been researched along with Capsule Opacification in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Eibl-Lindner, K; Kampik, A; Klingenstein, A; Kook, D; Mayer, WJ; Siedlecki, J; Wertheimer, C; Wolf, A1
Docheva, D; Eibl-Lindner, KH; Kampik, A; Kernt, M; Liegl, R; Mayer, W; Wertheimer, C1

Other Studies

2 other study(ies) available for quinazolines and Capsule Opacification

ArticleYear
EGFR inhibitor Gefitinib attenuates posterior capsule opacification in vitro and in the ex vivo human capsular bag model.
    Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2015, Volume: 253, Issue:3

    Topics: Adult; Aged; Capsule Opacification; Cell Line; Cell Movement; Cell Proliferation; Epithelial Cells; ErbB Receptors; Gefitinib; Humans; Lens, Crystalline; Materials Testing; Middle Aged; Neuroglia; Posterior Capsule of the Lens; Protein Kinase Inhibitors; Quinazolines; Retinal Pigment Epithelium

2015
EGF receptor inhibitor erlotinib as a potential pharmacological prophylaxis for posterior capsule opacification.
    Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2013, Volume: 251, Issue:6

    Topics: Adult; Aged; Capsule Opacification; Cell Line; Cell Movement; Cell Proliferation; Dose-Response Relationship, Drug; Epithelial Cells; ErbB Receptors; Erlotinib Hydrochloride; Humans; Middle Aged; Neuroglia; Posterior Capsule of the Lens; Protein Kinase Inhibitors; Quinazolines; Retinal Pigment Epithelium

2013